Nanobiotix S.A. (EPA:NANO)
46.18
+2.08 (4.72%)
May 14, 2026, 5:35 PM CET
Nanobiotix Employees
Nanobiotix had 100 employees as of December 31, 2025. The number of employees decreased by 8 or -7.41% compared to the previous year.
Employees
100
Change (1Y)
-8
Growth (1Y)
-7.41%
Revenue / Employee
€325,930
Profits / Employee
€239,610
Market Cap
2.14B
Employees Chart
Employees History
| Date | Employees | Change (1Y) | Growth (1Y) | Full-Time | Part-Time |
|---|---|---|---|---|---|
| Dec 31, 2025 | 100 | -8 | -7.41% | 100 | 0 |
| Dec 31, 2024 | 108 | 6 | 5.88% | 108 | 0 |
| Dec 31, 2023 | 102 | 0 | - | 102 | 0 |
| Dec 31, 2022 | 102 | 2 | 2.00% | 102 | 0 |
| Dec 31, 2021 | 100 | 10 | 11.11% | 100 | 0 |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro | Upgrade Pro | - |
Related Stocks
| Company Name | Employees |
|---|---|
| Valneva SE | 674 |
| Cellectis | 229 |
| Genfit | 188 |
| DBV Technologies | 161 |
| MedinCell | 145 |
| Transgene | 145 |
| Inventiva | 77 |
| ABIVAX Société Anonyme | 69 |
Nanobiotix News
- 9 days ago - Nanobiotix announces FDA acceptance of NANORAY-312 study protocol amendment - TheFly
- 9 days ago - Nanobiotix Announces Protocol Amendment to Ongoing Global Phase 3 Head and Neck Cancer Study - GlobeNewsWire
- 13 days ago - Nanobiotix price target raised to $30 from $3.50 at UBS - TheFly
- 24 days ago - Nanobiotix Announces Positive Preclinical Data For Nanoprimer In LNP-DNA Delivery - Nasdaq
- 24 days ago - Nanobiotix Announces New Preclinical Data Supporting Improved Systemic Bioavailability and Reduced Toxicity for LNP-Delivered DNA Immunotherapy After Pre-Treatment With Nanoprimer Technology - GlobeNewsWire
- 4 weeks ago - Nanobiotix price target raised to EUR 34 from EUR 32 at H.C. Wainwright - TheFly
- 5 weeks ago - Voting Rights and Shares Capital of the Company - GlobeNewsWire
- 6 weeks ago - Nanobiotix price target raised to $36 from $26 at Guggenheim - TheFly